Validation of Biomarkers and Immunotherapy in Head and Neck Squamous Cell Carcinoma using Bioinformatics and Mendelian Randomization

Background: To promote carcinogenesis through diverse molecular pathways involving dysregulation of gene expression and abnormalities.